Delisting risk
LEXX · NASDAQ · Biotechnology

Lexaria Bioscience

Developer and licensor of DehydraTECH oral drug-delivery technology.

$10.30
After-hours close−0.11 (−1.03%)
At close$10.41(−10.87%)
DateEstimateReportedSurprise
Oct 2026−$0.90
Jul 2026−$0.90−$1.20−33.3%
Apr 2026−$0.10−$0.06+40.0%
Jan 2026−$1.95−$0.07+96.4%
Jan 2026−$0.13−$0.07+46.2%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Nov 2025
Nov 2025
Jul 2025
Apr 2025
Jan 2025
Nov 2024
Nov 2024
Jul 2024
Apr 2024
Apr 2024
Jan 2024
Jan 2024
Nov 2023
Nov 2023
Jul 2023
Apr 2023
Jan 2023
Nov 2022
Jul 2022
Apr 2022
Jan 2022
Nov 2021
Jul 2021
Apr 2021
Jan 2021
Oct 2020
Oct 2020
Jun 2020
Apr 2020
Apr 2020
Jan 2020
Nov 2019
Jul 2019
Apr 2019
Apr 2019
Jan 2019
Nov 2018
Jul 2018
Apr 2018
Jan 2018
Nov 2017
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Oct 28, 2026−$0.90$50.0K
Jul 13, 2026−$0.90−$1.20−33.3%$50.0K
Apr 13, 2026−$0.10−$0.06+40.0%$50.0K$20.0K−60.0%
Jan 16, 2026−$1.95−$0.07+96.4%$100.0K
Jan 13, 2026−$0.13−$0.07+46.2%$100.0K

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Nov 26, 2025
Nov 25, 2025
Jul 14, 2025
Apr 14, 2025
Jan 10, 2025
Nov 26, 2024
Nov 19, 2024
Jul 12, 2024
Apr 12, 2024
Apr 9, 2024
Jan 16, 2024
Jan 12, 2024
Nov 24, 2023
Nov 21, 2023
Jul 14, 2023
Apr 14, 2023
Jan 17, 2023
Nov 25, 2022
Jul 14, 2022
Apr 11, 2022
Jan 14, 2022
Nov 29, 2021
Jul 15, 2021
Apr 14, 2021
Jan 14, 2021
Oct 15, 2020
Oct 14, 2020
Jun 30, 2020
Apr 3, 2020
Apr 2, 2020
Jan 8, 2020
Nov 14, 2019
Jul 8, 2019
Apr 15, 2019
Apr 12, 2019
Jan 11, 2019
Nov 14, 2018
Jul 13, 2018
Apr 12, 2018
Jan 12, 2018
Nov 27, 2017